Purchase Order HT942525P0076

The Defense Health Agency awarded a $14,943.24 firm fixed-price purchase order to Qiagen, LLC for maintenance services on September 30, 2024, with an ultimate completion date of September 29, 2025. This contract represents a task order issued under Qiagen's existing indefinite delivery contract vehicles with the Defense Health Agency, which include a $6.5 million Blanket Purchase Agreement for pharmaceutical products and consumables and a separate $489,895 Indefinite Delivery Contract for...

The Defense Health Agency awarded Qiagen, LLC a purchase order valued at $131,518 on September 16, 2020, for Ingenuity Pathway Analysis (IPA) Match Explorer Software. This firm fixed-price contract, which has no set-aside designation, was issued as a special notice procurement opportunity and is set to conclude on September 17, 2024. The work will be performed in Germantown, Maryland, where Qiagen maintains its U.S. headquarters. IPA Match Explorer is a bioinformatics software platform used...

The Defense Health Agency awarded a firm-fixed-price purchase order worth $55,002.15 to Qiagen, LLC, a division of the international provider Qiagen N.V., for pathology consultation and laboratory equipment. This award is not associated with a set-aside program. Qiagen has provided a range of products and services to support federal agencies' biomedical research, public health, law enforcement, and healthcare programs through past prime and sub-contract awards, including DNA/RNA extraction kits,...

This is a $97,350.04 firm fixed-price purchase order awarded by the Defense Health Agency to Qiagen, LLC, a subsidiary of the biotechnology company Qiagen N.V. The contract is for QIAGEN EQUIPMENT MAINTENANCE SERVICES and has a period of performance through September 28, 2024. No set-aside designation was used. Qiagen is a major provider of sample and assay technologies to federal agencies, supporting programs related to biomedical research, public health, law enforcement, and healthcare. This...

The Defense Health Agency awarded a purchase order to Qiagen, LLC for scientific equipment preventive maintenance at the Center of Infectious Disease Research in support of the Warfighter, with a ceiling value of $87,964.23 and an award date of September 30, 2025. Work is performed in Silver Spring, Maryland. The order carries firm fixed price terms and is not set-aside. Ultimate completion is scheduled for September 29, 2030. The procurement originated from a pre-solicitation opportunity posted...

This firm fixed-price purchase order was awarded by the Defense Health Agency to Qiagen, LLC, a division of the international provider Qiagen N.V. The $343,500.00 contract is for CLC Genomics Workbench network maintenance services with a completion date of September 27, 2024. Qiagen has provided equipment, software, reagents, and services to support federal biomedical research, public health, law enforcement, and healthcare programs through past prime and subcontracts. This work likely...

Qiagen, LLC was awarded a firm fixed-price purchase order valued at $43,679 by the Defense Health Agency on September 25, 2025, for equipment maintenance, repair, and preventative maintenance services related to Qiagen scientific equipment. The contract will be performed at Aberdeen Proving Ground, Maryland, with an ultimate completion date of September 24, 2026. This award was made without a set-aside designation, allowing Qiagen to compete in the open federal marketplace based on its...

The Defense Health Agency awarded a purchase order to Qiagen, LLC for an Ingenuity Pathway Analysis software license on September 27, 2023, with a ceiling value of $168,598.05 and a firm fixed price. No set-aside was used. Performance occurs in Silver Spring, Maryland, with ultimate completion scheduled for September 26, 2028. The order provides IPA Analysis Match Explorer software for genomics, transcriptomics, epigenomics, and metabolomics analysis and interpretation supporting biomarker...

The Defense Health Agency awarded a $167,309.55 firm fixed-price purchase order to Qiagen, LLC for Ingenuity Pathway Analysis (IPA) software licenses on September 17, 2025. The contract, with an ultimate completion date of September 16, 2030, represents a non-set-aside award to the foreign-owned molecular diagnostics and bioinformatics company headquartered in Germantown, Maryland. IPA software is a bioinformatics analysis platform used for interpreting genomic data and pathway analysis,...

This $83,927.20 firm fixed-price purchase order was awarded by the Defense Health Agency (DHA), a component of the U.S. Department of Defense, to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. The contract is for the delivery of EZ1 ADVANCED XL equipment, which is used for DNA/RNA extraction and sample preparation. This purchase order is not associated with a set-aside program. Qiagen has a history of providing specialized products and services to support...